600211 西藏药业
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额383,4511,004,751994,7911,063,422837,377
投资活动产生之现金流量净额(372,780)(589,074)354,486(831,884)(561,246)
筹资活动产生之现金流量净额97,936(122,623)(732,993)(483,685)(145,367)
汇率变动对现金及现金等价物的影响(21,091)(22,454)7,4387,04140,107
现金及现金等价物净增加/(减少)87,517270,599623,722(245,106)170,872
期初现金及现金等价物余额1,576,5001,305,901682,180927,286756,414
期末现金及现金等价物余额1,664,0171,576,5001,305,901682,180927,286